[
    [
        {
            "time": "2021-11-18",
            "original_text": "抗 癌 新 药 闯 关 失 败 恒 瑞 医 药 遇 挫 万 春",
            "features": {
                "keywords": [
                    "抗癌新药",
                    "恒瑞医药",
                    "万春",
                    "失败"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "抗 癌 新 药 闯 关 失 败 恒 瑞 医 药 遇 挫 万 春",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-11-20",
            "original_text": "投 资 新 药 上 市 申 请 遭 F D A 拒 绝！3 0 0 0 亿 市 值 医 药 龙 头 回 应：尚 未 进 行 股 权 交 割",
            "features": {
                "keywords": [
                    "FDA",
                    "拒绝",
                    "恒瑞医药",
                    "新药上市",
                    "股权交割"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "投 资 新 药 上 市 申 请 遭 F D A 拒 绝！3 0 0 0 亿 市 值 医 药 龙 头 回 应：尚 未 进 行 股 权 交 割",
                "Correlation": 9,
                "Sentiment": 2,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-11-22",
            "original_text": "F D A 打 击 了 万 春 药 业，却 擦 伤 了 恒 瑞？",
            "features": {
                "keywords": [
                    "FDA",
                    "万春药业",
                    "恒瑞",
                    "打击"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "F D A 打 击 了 万 春 药 业，却 擦 伤 了 恒 瑞？",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-11-25",
            "original_text": "万 春 医 药 新 药 上 市 遭 拒，恒 瑞 再 受 牵 连，新 药 研 发 会 是 “ 不 归 路 ” 吗？",
            "features": {
                "keywords": [
                    "万春医药",
                    "新药上市",
                    "遭拒",
                    "恒瑞",
                    "牵连"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "万 春 医 药 新 药 上 市 遭 拒，恒 瑞 再 受 牵 连，新 药 研 发 会 是 “ 不 归 路 ” 吗？",
                "Correlation": 9,
                "Sentiment": 3,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12-01",
            "original_text": "上 交 所 发 监 督 函，恒 瑞 研 发 费 用 资 本 化 始 末",
            "features": {
                "keywords": [
                    "上交所",
                    "监督函",
                    "恒瑞",
                    "研发费用",
                    "资本化"
                ],
                "sentiment_score": -0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上 交 所 发 监 督 函，恒 瑞 研 发 费 用 资 本 化 始 末",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-12-05",
            "original_text": "人 民 金 融 · 创 新 药 指 数 涨 1 . 1 8 % | 又 有 三 款 中 药 创 新 药 获 批，中 药 改 革 见 成 效",
            "features": {
                "keywords": [
                    "创新药指数",
                    "上涨",
                    "中药",
                    "获批",
                    "改革成效"
                ],
                "sentiment_score": 0.9,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "人 民 金 融 · 创 新 药 指 数 涨 1 . 1 8 % | 又 有 三 款 中 药 创 新 药 获 批，中 药 改 革 见 成 效",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-12-10",
            "original_text": "F D A 拒 绝 批 准 普 那 布 林 上 市 万 春 药 业 暴 跌 6 0 % 恒 瑞 微 跌 1 . 9 2 %",
            "features": {
                "keywords": [
                    "FDA",
                    "普那布林",
                    "拒绝",
                    "万春药业",
                    "暴跌",
                    "恒瑞",
                    "微跌"
                ],
                "sentiment_score": -0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "F D A 拒 绝 批 准 普 那 布 林 上 市 万 春 药 业 暴 跌 6 0 % 恒 瑞 微 跌 1 . 9 2 %",
                "Correlation": 10,
                "Sentiment": 2,
                "Importance": 10,
                "Impact": 10,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        }
    ]
]